SCHEMBL2914472

SCHEMBL2914472

COC(c1cc(F)cc(F)c1)C1(C(C(=O)NC2CCCCC2)C2CCCCC2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
TSHR P16473 2/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 2/20 0.33
IDO1 P14902 1/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 1/20 0.33
KCNH2 Q12809 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
ALDH1A1 P00352 2/20 0.32
CYP2C19 P33261 1/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
OPRL1 P41146 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910028 0.89 SMN1; SMN2 (0.45) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2913162 0.85 KMT2A (0.42) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL2908003 0.84 KMT2A (0.39) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL2912649 0.84 KMT2A (0.39) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL2915018 0.84 SMN1; SMN2 (0.41) MEN1KMT2ARAB9ASMN1; SMN2TSHR
SCHEMBL2912642 0.83 SMN1; SMN2 (0.43) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL2307838 0.82 NR1H4 (0.41) NPC1RAB9APOLBSMN1; SMN2TSHR
SCHEMBL2913040 0.76 TSHR (0.44) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2308785 0.76 NR1H4 (0.40) NPC1RAB9ASMN1; SMN2TSHRLMNA
SCHEMBL2307306 0.75 NR1H4 (0.41) MEN1KMT2ASMN1; SMN2TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed